G-CSF conjugate
US6027720A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jul 13, 1994 |
| Grant date | Feb 22, 2000 |
| Priority date | — |
| Expiry date | Jul 13, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/145
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel hG-CSF polypeptide derivatives having an amino acid sequence derived from the amino acid sequence of the human granulocyte colony stimulating factor polypeptide by substitution of at least one amino acid by a different amino acid and/or deletion of at least one amino acid, recombinant plasmids containing a DNA fragment insert coding for any of these hG-CSF polypeptide derivatives, microorganisms carrying one of such plasmids, methods of producing the hG-CSF polypeptide derivatives using the microorganisms, a monoclonal antibody binding to the hG-CSF polypeptide derivative, and chemically modified hG-CSF or derivatives thereof are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.